Apogee Therapeutics, Inc. (APGE) 8-K Current Report — March 2, 2026
Filed: March 2, 2026
Health Care
Biological Products, (No Diagnostic Substances)Apogee Therapeutics, Inc. (APGE) 8-K current report filed with SEC EDGAR on March 2, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 2.02: Results of Operations and Financial Condition
Apogee Therapeutics, Inc. 8-K Mar 2, 2026 Event Analysis
Item 2.02 · Results of Operations and Financial Condition
- • Full-year 2025 financial results released March 2, 2026 — see Exhibit 99.1 for key figures
- • Filing also includes a business update, suggesting pipeline or operational developments beyond financials
Get deeper insights on Apogee Therapeutics, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.